MedTrace Logo

Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease

NCT06908135 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-03-30

No results posted yet for this study

Summary

* Study Purpose: The purpose of the study is to compare changes in activity levels and walking in people with Parkinson disease after an 8-week independent walking program with or without using walking poles.
* Major parts of the Study:

Before the walking program: You will wear an activity sensor on your upper leg for one week to track activity levels. Measurements will be taken of you while you are walking. If you are placed in the walking pole group, you will be trained on how to use walking poles.

Independent walking program: You will be asked to walk at least 3 times each week for 8 weeks and keep a log of your walking. If you are in the walking pole group, you will walk with the poles.

After the walking program: Your walking measurements will be collected as before the walking program. You will wear an activity sensor for one week.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

Independent walking program using walking poles

Participants will independently walk at least 3 times a week for 8 weeks using walking poles

BEHAVIORAL

Independent walking program without walking poles

Participants will independently walk at least 3 times a week for 8 weeks without walking poles

Sponsors & Collaborators

  • Pacific Northwest University of Health Sciences

    lead OTHER

Principal Investigators

  • Tiffany Salido, DPT, PhD · Pacific Northwest University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-29
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06908135 on ClinicalTrials.gov